Randel William Woodgrift - 04 May 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Randel William Woodgrift by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
04 May 2022
Net transactions value
-$1,646,503
Form type
4
Filing time
05 May 2022, 18:12:36 UTC
Previous filing
05 Apr 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $1,065,600 +24,000 +50% $44.40 71,854 04 May 2022 Direct
transaction ABT Common shares without par value Sale $2,712,103 -24,000 -33% $113.00 47,854 04 May 2022 Direct F1
holding ABT Common shares without par value 3,323 04 May 2022 Profit Sharing Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -24,000 -45% $0.000000 29,271 04 May 2022 Common Shares 24,000 $44.40 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.06, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 Balance in the Abbott Laboratories Stock Retirement Trust as of May 4, 2022.
F3 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.